Announced Mon, 3 Aug · 14:52 IST
Board meeting on 11 Aug 2026 to consider Q1FY27 results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.0%1-day move
₹39.50
prior close
₹40.69
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-1.0+0.8-3.5+0.0+0.8-0.5-3.8-0.3——
Up moveDown movePending
AI summary
Sandu Pharmaceuticals has informed BSE that its Board of Directors will meet on 11 August 2026 at 4:00 pm at the corporate office in Chembur, Mumbai. The main agenda is to consider and approve the standalone unaudited financial results for the quarter ended 30 June 2026. Any other matter with the Chair's permission may also be taken up. The trading window for insiders is closed from 1 July 2026 until 48 hours after results are announced.
Likely market impact
Routine intimation; no material impact on stock. Watch for Q1FY27 results on 11 Aug 2026 for earnings direction.